The second study that tested a COVID-19 antibody has a setback – AlKhaleej Today

For the second time, a study testing an experimental antibody drug for COVID-19 has been suspended to investigate a possible safety issue in hospitalized patients.Regeneron Pharmaceuticals Inc. said Friday that independent observers had recommended that the most critically ill patients those who require intensive oxygen treatment or breathing apparatus be put on hold because of a potential safety issue and an adverse balance of risks and benefits. The study can continue to test the combination of…

Click here to view the original article.